UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000043318 |
|---|---|
| Receipt number | R000047967 |
| Scientific Title | Effect of the exercise therapy during hemodialysis on the patients of arteriosclerosis obliterans |
| Date of disclosure of the study information | 2021/03/31 |
| Last modified on | 2021/02/13 16:00:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of the exercise therapy during hemodialysis on the patients of arteriosclerosis obliterans
Acronym
Effect of the exercise therapy during hemodialysis
Scientific Title
Effect of the exercise therapy during hemodialysis on the patients of arteriosclerosis obliterans
Scientific Title:Acronym
Effect of the exercise therapy during hemodialysis
Region
| Japan |
Condition
Condition
arteriosclerosis obliterans
Classification by specialty
| Nephrology | Vascular surgery | Rehabilitation medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The objective of this study is to investigate whether exercise therapy during hemodialysis prevents deterioration of activities of daily life, maintains muscle strength, increases peripheral circulation, and shortens the length of hospitalization.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
increase of peripheral circulation oxygen and partial pressure by exercise therapy during hemodialysis
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Behavior,custom |
Interventions/Control_1
exercise therapy during hemodialysis
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) inpatients with ASO Rutherford criteria
Key exclusion criteria
bed-bound patient
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | SATO |
| Middle name | |
| Last name | MIYU |
Organization
TOKYO MEDICAL AND DENTAL UNIVERSITY MEDICAL HOSPITAL
Division name
Blood purification therapy department
Zip code
1138519
Address
1-5-45 Yushima Bunkyo-ku Tokyo
TEL
0338135662
m.fujimaki.mnrs@tmd.ac.jp
Public contact
Name of contact person
| 1st name | SATO |
| Middle name | |
| Last name | MIYU |
Organization
TOKYO MEDICAL AND DENTAL UNIVERSITY MEDICAL HOSPITAL
Division name
Blood purification therapy department
Zip code
1138519
Address
1-5-45 Yushima Bunkyo-ku Tokyo
TEL
0338135662
Homepage URL
m.fujimaki.mnrs@tmd.ac.jp
Sponsor or person
Institute
Ministry of education
Institute
Department
Personal name
Funding Source
Organization
TOKYO MEDICAL AND DENTAL UNIVERSITY MEDICAL HOSPITAL Nephrology
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
TOKYO MEDICAL AND DENTAL UNIVERSITY MEDICAL HOSPITAL Blood purification therapy department
Address
1-5-45 Yushima Bunkyo-ku Tokyo
Tel
0338135662
m.fujimaki.mnrs@tmd.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 03 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2020 | Year | 04 | Month | 30 | Day |
Date of IRB
Anticipated trial start date
| 2021 | Year | 03 | Month | 20 | Day |
Last follow-up date
| 2021 | Year | 04 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 02 | Month | 13 | Day |
Last modified on
| 2021 | Year | 02 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047967
